Cwm, LLC Liquidia Corp Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Cwm, LLC holds 332 shares of LQDA stock, worth $8,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares

332

Previous 421 21.14%

Holding current value

$8,203

Previous $5,000 60.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$12.06 - $28.85 $1,073 - $2,567	-89 Reduced 21.14%	332 $8,000
Q2 2025 Jul 25, 2025	SELL	$11.99 - $19.3 $971 - $1,563	-81 Reduced 16.14%	421 $5,000
Q1 2025 May 01, 2025	BUY	$11.36 - $16.5 $4,044 - $5,874	356 Added 243.84%	502 $7,000
Q4 2024 Feb 04, 2025	BUY	$9.82 - $11.8 $422 - $507	43 Added 41.75%	146 $2,000
Q3 2024 Oct 08, 2024	SELL	$8.9 - $14.11 $1,824 - $2,892	-205 Reduced 66.56%	103 $1,000
Q2 2024 Jul 09, 2024	BUY	$11.96 - $15.71 $1,674 - $2,199	140 Added 83.33%	308 $4,000
Q1 2024 Apr 05, 2024	BUY	$11.35 - $16.73 $1,906 - $2,810	168 New	168 $2,000

Others Institutions Holding LQDA

# of Institutions

215

Shares Held

47.5M

Call Options Held

1.61M

Put Options Held

1.15M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $1.59B
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account